Tumour marker CA 125 in patients with digestive tract malignancies.
about
Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancerIdentification of differentially expressed serum proteins in gastric adenocarcinoma.Overexpression of HOXB7 is associated with a poor prognosis in patients with gastric cancerDiagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry
P2860
Tumour marker CA 125 in patients with digestive tract malignancies.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Tumour marker CA 125 in patients with digestive tract malignancies.
@en
type
label
Tumour marker CA 125 in patients with digestive tract malignancies.
@en
prefLabel
Tumour marker CA 125 in patients with digestive tract malignancies.
@en
P2093
P2860
P1476
Tumour marker CA 125 in patients with digestive tract malignancies.
@en
P2093
P2860
P304
P356
10.3109/00365519109091613
P577
1991-05-01T00:00:00Z